SG11202002281YA - Nasal hepatitis b vaccine composition and method for producing same - Google Patents
Nasal hepatitis b vaccine composition and method for producing sameInfo
- Publication number
- SG11202002281YA SG11202002281YA SG11202002281YA SG11202002281YA SG11202002281YA SG 11202002281Y A SG11202002281Y A SG 11202002281YA SG 11202002281Y A SG11202002281Y A SG 11202002281YA SG 11202002281Y A SG11202002281Y A SG 11202002281YA SG 11202002281Y A SG11202002281Y A SG 11202002281YA
- Authority
- SG
- Singapore
- Prior art keywords
- vaccine composition
- producing same
- hepatitis
- nasal
- nasal hepatitis
- Prior art date
Links
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017195262 | 2017-10-05 | ||
| PCT/JP2018/037172 WO2019070019A1 (ja) | 2017-10-05 | 2018-10-04 | 経鼻ｂ型肝炎ワクチン組成物およびその製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202002281YA true SG11202002281YA (en) | 2020-04-29 |
Family
ID=65994315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202002281YA SG11202002281YA (en) | 2017-10-05 | 2018-10-04 | Nasal hepatitis b vaccine composition and method for producing same |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11491219B2 (ko) |
| EP (1) | EP3693006A4 (ko) |
| JP (2) | JPWO2019070019A1 (ko) |
| KR (1) | KR102673991B1 (ko) |
| CN (1) | CN111344005A (ko) |
| AU (1) | AU2018345493A1 (ko) |
| BR (1) | BR112020005695A2 (ko) |
| CA (1) | CA3075423A1 (ko) |
| IL (1) | IL273168B1 (ko) |
| MX (1) | MX2020003753A (ko) |
| PH (1) | PH12020550211A1 (ko) |
| SG (1) | SG11202002281YA (ko) |
| TW (1) | TWI811248B (ko) |
| WO (1) | WO2019070019A1 (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024048570A1 (ja) * | 2022-08-30 | 2024-03-07 | 国立大学法人愛媛大学 | 経鼻投与用ｂ型肝炎ワクチン組成物および該ワクチン組成物の経鼻投与システム |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5158761A (en) * | 1989-04-05 | 1992-10-27 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
| CN1171636C (zh) * | 2001-06-06 | 2004-10-20 | 中国人民解放军第二军医大学 | 一种乙型肝炎dna疫苗 |
| CU23031A1 (es) * | 2002-01-24 | 2005-02-23 | Ct Ingenieria Genetica Biotech | Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes |
| CU23405A1 (es) | 2003-10-20 | 2009-08-04 | Ct Ingenieria Genetica Biotech | Composiciones farmacéuticas para uso terapéutico |
| SI2011467T1 (sl) | 2006-04-21 | 2021-01-29 | Toko Yakuhin Kogyo Kabushiki Kaisha | Posoda za tekočino in brezzračni sistem za razdeljevanje tekočine |
| DK2014305T3 (en) | 2006-04-21 | 2017-10-16 | Toko Yakuhin Kogyo Kk | SPRAYABLE GEL-SHAPED SKIN / MOSPHONE ADHESIVE AND ADMINISTRATIVE SYSTEM FOR USING THE PREPARATION |
| AU2013367751B2 (en) * | 2012-12-28 | 2018-02-08 | Japan As Represented By Director General Of National Institute Of Infectious Diseases | Nasal influenza vaccine composition |
| JP6322844B2 (ja) | 2014-06-25 | 2018-05-16 | 東興薬品工業株式会社 | 医療用シリンジに用いられる点鼻用噴霧ノズル |
-
2018
- 2018-10-04 BR BR112020005695-2A patent/BR112020005695A2/pt unknown
- 2018-10-04 WO PCT/JP2018/037172 patent/WO2019070019A1/ja unknown
- 2018-10-04 IL IL273168A patent/IL273168B1/en unknown
- 2018-10-04 US US16/652,935 patent/US11491219B2/en active Active
- 2018-10-04 CN CN201880059580.8A patent/CN111344005A/zh active Pending
- 2018-10-04 AU AU2018345493A patent/AU2018345493A1/en active Pending
- 2018-10-04 JP JP2019547008A patent/JPWO2019070019A1/ja active Pending
- 2018-10-04 SG SG11202002281YA patent/SG11202002281YA/en unknown
- 2018-10-04 EP EP18864669.9A patent/EP3693006A4/en active Pending
- 2018-10-04 MX MX2020003753A patent/MX2020003753A/es unknown
- 2018-10-04 TW TW107135105A patent/TWI811248B/zh active
- 2018-10-04 CA CA3075423A patent/CA3075423A1/en active Pending
- 2018-10-04 KR KR1020207012527A patent/KR102673991B1/ko active IP Right Grant
-
2020
- 2020-04-03 PH PH12020550211A patent/PH12020550211A1/en unknown
-
2022
- 2022-11-07 JP JP2022178036A patent/JP2023012539A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TWI811248B (zh) | 2023-08-11 |
| KR20200071742A (ko) | 2020-06-19 |
| JPWO2019070019A1 (ja) | 2020-10-22 |
| TW201922226A (zh) | 2019-06-16 |
| US11491219B2 (en) | 2022-11-08 |
| IL273168B1 (en) | 2024-03-01 |
| BR112020005695A2 (pt) | 2020-10-06 |
| US20200261568A1 (en) | 2020-08-20 |
| WO2019070019A1 (ja) | 2019-04-11 |
| EP3693006A4 (en) | 2021-07-07 |
| MX2020003753A (es) | 2020-11-09 |
| JP2023012539A (ja) | 2023-01-25 |
| PH12020550211A1 (en) | 2021-02-15 |
| RU2020115051A3 (ko) | 2021-11-18 |
| CN111344005A (zh) | 2020-06-26 |
| IL273168A (en) | 2020-04-30 |
| EP3693006A1 (en) | 2020-08-12 |
| AU2018345493A1 (en) | 2020-04-02 |
| RU2020115051A (ru) | 2021-11-08 |
| KR102673991B1 (ko) | 2024-06-10 |
| CA3075423A1 (en) | 2019-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258288B (en) | Hair strengthening compound and hair strengthening method | |
| ZA201804362B (en) | Mutant virus, preparation method therefor and application thereof | |
| GB201814362D0 (en) | Composition and process for preparing vaccine | |
| PL3213576T3 (pl) | Układ i sposób ustawiania długości prefiksu cyklicznego | |
| EP3299415A4 (en) | Heat-resistant resin composition and method for producing same | |
| PH12017500003A1 (en) | Vaccine composition for classical swine fever from plant and manufacturing method thereof | |
| PL3309138T3 (pl) | Sposób koprodukcji 2,3,3,3-tetrafluoropropylenu i 1,3,3,3-tetrafluoropropylenu | |
| IL269460B (en) | Adhesive preparation and method for its preparation | |
| HK1254944A1 (zh) | 微針及其製造方法 | |
| PL3053902T3 (pl) | Przedmiot ceramiczny i sposób jego wytwarzania | |
| PL3348567T3 (pl) | Nowy wariant białka do transportu O-fosfoseryny oraz sposób produkcji O-fosfoseryny, cysteiny i ich pochodnych z jego zastosowaniem | |
| PL3265709T3 (pl) | Kanał i sposób jego wytwarzania | |
| EP3332732A4 (en) | ORTHODONTIC COMPOSITE AND METHOD FOR PREPARING THE SAME | |
| PL3432315T3 (pl) | Kompozycja betonu i sposób wytwarzania takiej kompozycji betonu | |
| HK1244805A1 (zh) | 一種新毒素及其中間體的製備方法 | |
| HUE043410T2 (hu) | Kerámia tárgy és eljárás ilyen elõállítására | |
| ZA201908090B (en) | Pharmaceutical composition and method for preparing same | |
| SG10201606180YA (en) | Photomask Blank And Method For Preparing Photomask | |
| IL273168A (en) | A compound for an epidural vaccine of hepatitis B and its production | |
| HK1244862A1 (zh) | 高密度空氣的製造方法以及利用方法 | |
| ZA202101026B (en) | Methods and compositions for producing a virus | |
| PT3727540T (pt) | Cânula traqueal e método de fabrico | |
| IL267094A (en) | Method for producing 3-(pyridyl-2-amino)propionitrile and analogues thereof | |
| GB201708779D0 (en) | Virus and method | |
| GB201708778D0 (en) | Virus and method |